| P2093 | author name string | Jianhua Li | |
| | Zhenghong Yuan | |
| | Min Wu | |
| | Fan Wang | |
| | Wen Zhang | |
| | Ye Zheng | |
| | Cuncun Chen | |
| | Jieliang Chen | |
| | Junyu Lin | |
| | Xiuhua Peng | |
| P2860 | cites work | Multiplex genome engineering using CRISPR/Cas systems | Q24609428 |
| | Targeted DNA mutagenesis for the cure of chronic viral infections | Q24620150 |
| | Predictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approach | Q27324340 |
| | Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy | Q28254997 |
| | A simple cipher governs DNA recognition by TAL effectors | Q28265506 |
| | A TALE nuclease architecture for efficient genome editing | Q28301656 |
| | Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues | Q28321734 |
| | Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures | Q29615028 |
| | Hepatitis B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral screening assays | Q33247082 |
| | Comparative study of anti-hepatitis B virus RNA interference by double-stranded adeno-associated virus serotypes 7, 8, and 9. | Q33713259 |
| | Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs | Q33756729 |
| | Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. | Q33834863 |
| | Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein | Q33865474 |
| | Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs. | Q33931634 |
| | Inhibition of hepatitis B virus replication by MyD88 involves accelerated degradation of pregenomic RNA and nuclear retention of pre-S/S RNAs | Q33990530 |
| | Chronic hepatitis B. | Q34002160 |
| | Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro | Q34105204 |
| | A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity. | Q34205743 |
| | Hepatitis B virus: pathogenesis, viral intermediates, and viral replication | Q35916716 |
| | Highly efficient generation of heritable zebrafish gene mutations using homo- and heterodimeric TALENs | Q36228544 |
| | Carbonyl J acid derivatives block protein priming of hepadnaviral P protein and DNA-dependent DNA synthesis activity of hepadnaviral nucleocapsids. | Q36246202 |
| | Cellular and molecular mechanisms of liver tolerance | Q36593734 |
| | Single amino acid substitutions uncouple the DNA binding and strand scission activities of Fok I endonuclease. | Q36601344 |
| | Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection | Q36883851 |
| | Inhibition of hepatitis B virus gene expression and replication by ribonuclease P. | Q36883874 |
| | Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. | Q37418293 |
| | Control of cccDNA function in hepatitis B virus infection. | Q37555389 |
| | Drug delivery systems and liver targeting for the improved pharmacotherapy of the hepatitis B virus (HBV) infection | Q37718052 |
| | The innate immune response to hepatitis B virus infection: implications for pathogenesis and therapy | Q38052681 |
| | New insights into how HBV manipulates the innate immune response to establish acute and persistent infection | Q38077876 |
| | Hepatitis B virus surface antigen selectively inhibits TLR2 ligand-induced IL-12 production in monocytes/macrophages by interfering with JNK activation | Q39166522 |
| | Hepatitis B virus polymerase impairs interferon-α-induced STA T activation through inhibition of importin-α5 and protein kinase C-δ. | Q39274712 |
| | Are novel combination therapies needed for chronic hepatitis B? | Q39549118 |
| | Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilo | Q39717470 |
| | Inhibition of hepatitis B virus gene expression and replication by endoribonuclease-prepared siRNA. | Q39996745 |
| | Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication | Q40275011 |
| | IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome | Q40679075 |
| | In vivo genome editing using a high-efficiency TALEN system | Q41438039 |
| | Characterization of nucleosome positioning in hepadnaviral covalently closed circular DNA minichromosomes | Q41816507 |
| | Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE Nucleases. | Q41825244 |
| | Zinc finger proteins designed to specifically target duck hepatitis B virus covalently closed circular DNA inhibit viral transcription in tissue culture | Q42041585 |
| | Exosomes mediate the cell-to-cell transmission of IFN-α-induced antiviral activity | Q42285504 |
| | Assessment of recombinant adenoviral vectors for hepatic gene therapy | Q43425277 |
| | Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells | Q45208404 |
| | Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins | Q45722565 |
| | Relationships within and between genotypes of hepatitis B virus at points across the genome: footprints of recombination in certain isolates | Q45744944 |
| | Inhibition of interferon-inducible MxA protein expression by hepatitis B virus capsid protein | Q45749129 |
| | Gene editing: not just for translation anymore | Q46216698 |
| | Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells | Q64389793 |
| P433 | issue | 2 | |
| P921 | main subject | Hepatitis B virus | Q6844 |
| | hepatitis B | Q6853 |
| P304 | page(s) | 303-311 | |
| P577 | publication date | 2013-09-12 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | An efficient antiviral strategy for targeting hepatitis B virus genome using transcription activator-like effector nucleases | |
| P478 | volume | 22 | |